The Patent Finder

Neurotensin Receptor Ligands

3B Pharmaceuticals GmbH

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 10,961,199Neurotensin Receptor Ligands
In force
 · High confidence
UsedRemaining
3B Pharmaceuticals GmbHIn forceHigh confidence
Application 17/112,258Neurotensin Receptor Ligands
Abandoned
Abandoned Jul 29, 2025
3B Pharmaceuticals GmbHAbandonedAbandoned Jul 29, 2025
Application 19/222,493Neurotensin Receptor Ligands
Pending
Not granted
3B Pharmaceuticals GmbHPendingNot granted
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by 3B Pharmaceuticals GmbH.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited